“`html
McKesson Corporation (MCK) stock has increased by 6% over the past month, outpacing the S&P 500’s 4% gain and the Zacks Medical – Dental Supplies industry’s -0.6% decline. As of the current fiscal quarter, McKesson is projected to report earnings of $7.18 per share, which reflects a -1.2% change from the previous year, with a consensus estimate for the fiscal year at $31.47, signifying a +14.7% year-over-year increase.
McKesson’s consensus sales estimate for the current quarter stands at $83.36 billion, indicating a +11.9% annual change. The company’s latest reported revenues were $76.36 billion for the previous quarter, marking a 10.8% increase year-over-year. The consensus estimate for the next fiscal year is $35.31 per share, a +12.2% increase over last year.
Currently, McKesson holds a Zacks Rank of #3 (Hold), suggesting its performance may align with the broader market in the near term. The stock is evaluated as trading at a discount compared to its peers, receiving an A grade in Zacks Value Style Score.
“`
